Skip to main content

BioTechniques is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Aims and scope
    • Journal archive
    • Editorial board
    • For authors
    • Your editors: what do we do?

    Follow us on social media

  • Current issue
  • News
    • Latest news
    • Tech news
    • Events news
    • Company news

    Follow us on social media

  • Multimedia
    • Downloadable eBooks
    • Infographics
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • Features
    • Interviews
    • Opinion
    • In Focus
    • Spotlights
    • Companies
    • New products
    • Events

    Follow us on social media

  • Topics
    • Analytical chemistry
      • Biochemistry
      • Bioengineering and biophysics
      • Cancer research
      • Careers and Publishing
      • Cell and tissue biology
      • COVID-19
      • CRISPR
      • Computational biology
    • Diagnostics and preclinical
      • Drug discovery and development
      • Imaging
      • Immunology
      • Lab design and machinery
      • Microbiology
      • Molecular biology
    • Nanomedicine
      • Neuroscience
      • PCR and sequencing
      • Plant and climate science
      • Proteomics
      • Veterinary science
      • Whole-genome studies

    Follow us on social media

  • Become a member
Webinar | How to sequence full-length 16S and ITS microbial amplicons 5 days 7 hours 47 mins 52 secs Sign up now!

Revealing more to transform human health

26 Feb 2024
Written by Oxford Nanopore
PCR and sequencing Whole-genome studies

From fusions to full-length transcript isoforms, methylation to complex copy-number variations, nanopore technology helps you reveal powerful information about underlying causes of disease.

In this short video, hear how researchers are using the technology to produce rich datasets – powering bigger and bolder research questions.

For more information, check out:

  • Case study: Characterizing methylation markers in imprinting disorders
  • Case study: Improving the characterization of mutations driving blood cancer
  • Case study: Direct methylation detection enables new view of multiple sclerosis
  • Case study: Ultra-rich nanopore data offers unprecedented insights into the transcriptomes of single cells

This video was provided by Oxford Nanopore.

Related tags

nanopore Oxford Nanopore sequencing
Previous article Next article

Related articles

17 MAY 2023 PCR AND SEQUENCING

Sequencing to fight COVID-19 with Oxford Nanopore

17 MAY 2023 PCR AND SEQUENCING

The most comprehensive insight into cancer genomes

15 OCT 2021 PCR AND SEQUENCING

The role of nanopore sequencing in pandemic responses around the world

Detecting DNA methylation in the human genome
17 NOV 2021 WHOLE-GENOME STUDIES

Detecting DNA methylation in the human genome

28 AUG 2024 PCR AND SEQUENCING

Meet the next generation of portable sequencing

12 OCT 2023 PCR AND SEQUENCING

Nanopore sequencing: the most comprehensive insight into cancer genomes

  • About BioTechniques
  • Advisory Board
  • Contact Us
  • Advertising
  • Permissions
  • Whitelist Emails
  • Press release policy
  • Accessibility
Contact
Contact Us
Office info

BioTechniques is powered by Taylor & Francis Group

BioTechniques, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom

Impact Factor 2.2 | CiteScore 2.0

  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 BioTechniques